Transforming growth factor-beta isoforms in mammary neoplasia: more questions than answers

Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.

NPJ precision oncology·2022

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Enteric glial cell remodeling at diagnosis is associated with reduced mucosal inflammation at follow-up in pediatric ulcerative colitis.

Human pathology·2026

Comparative distribution of HPV genotypes in penile and vulvar squamous cell carcinomas with basaloid or warty (condylomatous) features.

Human pathology·2026

Detection of androgen receptor (AR) splice variants across diverse prostatic and non-prostatic tumor types using the TruSight Oncology 500 (TSO500) assay.

Human pathology·2026

L1CAM expression in eosinophilic solid and cystic renal cell carcinoma: clinicopathologic and immunophenotypic insights from a multicenter cohort.

Human pathology·2026

Co-occurrence of bronchiolar adenoma and lung adenocarcinoma: a study of nine cases revealing distinct clonal origins via integrated histologic, immunophenotypic and molecular analysis.

Human pathology·2026

Sarcomatoid malignancies with strong PD-L1 expression often represent dedifferentiated or undifferentiated melanomas.

Human pathology·2026

Restraint stress impairs oocyte maturation via dysregulating stage-dependent estradiol-BMAL rhythm in mice.

Reproduction (Cambridge, England)·2026

Unveiling the oncogenic role of PDK3 in head and neck squamous cell carcinoma, an integrative in silico and an in vitro approach.

Journal, genetic engineering & biotechnology·2026

Recognizing the significance of cancer-nerve crosstalk in advanced prostate cancer.

Advances in cancer research·2026

[Finite element analysis of CT-based lateral classification of Japanese Investigation Committee type C1 osteonecrosis of femoral head and its prognostic value].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery·2026

Advances in Calcium Transients and Autophagy.

The international journal of biochemistry & cell biology·2026

Neural Remodeling Shapes a Nerve-Dependent Metastatic Ecosystem in Ovarian Cancer.

Pharmacological research·2026

Related Experiment Videos

Transforming growth factor-beta isoforms in mammary neoplasia: more questions than answers

Related Concept Videos

Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials.

Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

Enteric glial cell remodeling at diagnosis is associated with reduced mucosal inflammation at follow-up in pediatric ulcerative colitis.

Comparative distribution of HPV genotypes in penile and vulvar squamous cell carcinomas with basaloid or warty (condylomatous) features.

Detection of androgen receptor (AR) splice variants across diverse prostatic and non-prostatic tumor types using the TruSight Oncology 500 (TSO500) assay.

L1CAM expression in eosinophilic solid and cystic renal cell carcinoma: clinicopathologic and immunophenotypic insights from a multicenter cohort.

Co-occurrence of bronchiolar adenoma and lung adenocarcinoma: a study of nine cases revealing distinct clonal origins via integrated histologic, immunophenotypic and molecular analysis.

Sarcomatoid malignancies with strong PD-L1 expression often represent dedifferentiated or undifferentiated melanomas.

Restraint stress impairs oocyte maturation via dysregulating stage-dependent estradiol-BMAL rhythm in mice.

Unveiling the oncogenic role of PDK3 in head and neck squamous cell carcinoma, an integrative in silico and an in vitro approach.

Recognizing the significance of cancer-nerve crosstalk in advanced prostate cancer.

[Finite element analysis of CT-based lateral classification of Japanese Investigation Committee type C1 osteonecrosis of femoral head and its prognostic value].

Advances in Calcium Transients and Autophagy.

Neural Remodeling Shapes a Nerve-Dependent Metastatic Ecosystem in Ovarian Cancer.

Related Experiment Videos

Transforming growth factor-beta isoforms in mammary neoplasia: more questions than answers

Related Concept Videos

Related Articles